{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/10/3341758/0/en/elicio-therapeutics-announces-activation-of-the-investigator-initiated-phase-1-study-of-neoadjuvant-eli-002-7p-for-pancreatic-ductal-adenocarcinoma.html", "message": "News view counter 871999 successfully enlarged"}